Commercial weight loss programme evaluated

September 20, 2012 in Overweight and Obesity

(Medical Xpress)—Anyone who wants to lose weight has a wide variety of diets to choose from, but knowledge of what works is often poor. Researchers at Karolinska Institutet and Uppsala University have now evaluated a Swedish commercial weight loss programme called Itrim, and found it to be effective. After one year, participants had lost 11 kg on average.

"Most of the participants lost a lot of weight in the first three months and then showed very good weight stability after one year," says Erik Hemmingsson, researcher at Karolinska Institutet and Karolinska University Hospital's Centre. "However, we still don't know what happens in the longer term. Maintaining the lower weight is without a doubt the greatest challenge for ."

Itrim is based on available research on sustained weight loss through and exercise. Each participant selects one of three diets at the start of the at a minimum one-year programme: a very low calorie diet (VLCD, 500 kcal/day consisting solely of meal replacements for 6-10 weeks); a (LCD, 1200-1500 kcal/day consisting of a mix of normal food and meal replacements); or a calorie-restricted normal food diet (1500-1800 kcal/day). The program also consists of group sessions, individual booster sessions and exercise. People wishing to go on the most rigorous VLCD programme are required to see a physician at the start in order to minimize .

The effectiveness of the programme was evaluated by measuring weight loss in 9037 participants after one year. The mean age was 48 and the majority of the were women. Forty-two percent chose the VLCD diet, 51 percent the LCD diet, and seven percent the calorie-restricted normal food diet.

The study, which is published in the scientific journal , found that the overall weight loss was 10.9 kg (or 12 percent of the starting weight) after one year. The participants on the VLCD programme lost most weight, on average 13.8 kg (or 14 percent of the starting weight). The LCD and calorie-restricted normal participants lost 8.9 kg (10 percent) and 7 kg (8 percent) respectively.

Twenty-one percent of all participants dropped out of the programme. The lowest dropout rate was seen in the VLCD group (18 percent), followed by the LCD group (23 percent) and the restricted diet group (26 percent). Risk factors for dropout included low age, low starting BMI and low initial weight loss.

Participation in the Itrim programme costs about SEK 9000 a year (about $1300, ¬1000). According to Dr Hemmingsson, healthcare services in Sweden lack resources to help overweight and obese people lose weight, which is a problem.

"Many overweight people therefore turn to commercial programs, where the effects often are unclear," he says. "So we really need to evaluate commercial weight loss programmes."

More information: Erik Hemmingsson et al., Weight loss and dropout during a commercial weight loss program using VLCD, LCD and restricted normal food: observational cohort study. American Journal of Clinical Nutrition, online ahead of print 19 September 2012. ajcn.nutrition.org… 58c6d7de4f6e

Journal reference: American Journal of Clinical Nutrition search and more info website

Provided by Karolinska Institutet search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Genetic risk for obesity found in many Mexican young adults

As many as 35 percent of Mexican young adults may have a genetic predisposition for obesity, said a University of Illinois scientist who conducted a study at the Universidad Autónoma de San Luis Potosί.

Overweight and Obesity created 2 hours ago | popularity not rated yet | comments 0

'Doctor shopping' by obese patients negatively affects health

Overweight and obese patients are significantly more likely than their normal-weight counterparts to repeatedly switch primary care doctors, a practice that disrupts continuity of care and leads to more emergency room visits, ...

Overweight and Obesity created 4 hours ago | popularity not rated yet | comments 0

Child maltreatment increases risk of adult obesity

Children who have suffered maltreatment are 36% more likely to be obese in adulthood compared to non-maltreated children, according to a new study by King's College London. The authors estimate that the prevention or effective ...

Overweight and Obesity created 14 hours ago | popularity not rated yet | comments 0

Young children appear to reject story characters who are obese

(Medical Xpress)—Research by the University of Leeds has shown that very young children appear to reject story book characters who are overweight, but not those who are disabled.

Overweight and Obesity created May 16, 2013 | popularity 3 / 5 (1) | comments 4

Gene variations may explain weight gain among men, women

(HealthDay)—Weight gain in men and women is predicted by two different genetic variations—so-called polymorphisms, according to a new study from the Netherlands.

Overweight and Obesity created May 15, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Researchers find genetic risk factor for pulmonary fibrosis

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Post-approval TAVI registry shows high rates of device success at one year

One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...